This page includes the latest FDA filings for Acelrx Pharmaceuticals Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
USA | NASDAQ | ACRX | DUNS 789244774 |
Device Company | Device | Date |
---|---|---|
AcelRx Pharmaceuticals, Inc., Patheon Pharmaceuticals Inc. | Prescription Medication | 2023-12-22 |
AcelRx Pharmaceuticals, Inc., Patheon Pharmaceuticals Inc. | Prescription Medication | 2019-10-19 |
AcelRx Pharmaceuticals, Inc | Dsuvia | 2018-11-02 |
NCAGE Code | 5ZVQ4 | ACELRX PHARMACEUTICALS, INC. |
CAGE Code | 5ZVQ4 | ACELRX PHARMACEUTICALS, INC. |
S.A.M. Registration | 5ZVQ4 [789244774] | ACELRX PHARMACEUTICALS, INC. |
SEC | 0001427925 | ACELRX PHARMACEUTICALS INC of DELAWARE |